Fortis Healthcare gets CCI nod to acquire additional stake in Agilus Diagnostics for Rs 1,780 cr

The Competition Commission of India (CCI) has approved Fortis Healthcare's acquisition of an additional 31.52% stake in Agilus Diagnostics, raising its total share to 89.2%. Additionally, CCI has greenlit the merger of Diliigent Power into DB Power and the reorganisation of Decore Thermal Power.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bQkLmIr
via IFTTT